Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2016-11-11 Audit Report / Informat…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
105年第3季財務報告書 — 201604_3164_AI3.pdf
Audit Report / Information Classification · 100% confidence The document is titled as an individual financial report and auditor's report for the fiscal years 105 and 104 (Taiwanese calendar years corresponding to 2016 and 2015). It contains detailed financial statements including balance sheets, income statements, cash flow statements, notes to financial statements, and an auditor's opinion. The presence of an auditor's report integrated with the financial statements indicates this is a standalone audit report rather than a full annual report. The document length is substantial (15,000 characters), and it includes detailed financial data and audit opinions, not merely an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2016
2016-11-11 Chinese
105年第3季財務報告書 — 201604_3164_AI1.pdf
Annual Report Classification · 95% confidence The document is titled as a consolidated financial report and auditor's report for the fiscal years 105 and 104 (which correspond to 2016 and 2015 in the Gregorian calendar) for 景岳生物科技股份有限公司及子公司 (Jingyue Biotechnology Co., Ltd. and subsidiaries). It includes detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements. It also contains the auditor's opinion and detailed audit procedures, key audit matters, and management responsibilities. The presence of the auditor's report integrated with the consolidated financial statements indicates this is a full annual report document. The document length is about 15,000 characters, which is consistent with a full report rather than a short announcement. Therefore, this document is best classified as an Annual Report (10-K equivalent). FY 2016
2016-11-11 Chinese
105年第3季財務報告書 — 201603_3164_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Accountant's Review Report" for the third quarter of years 105 and 104 (in the Taiwanese calendar, corresponding to 2016 and 2015). It includes detailed financial statements such as consolidated balance sheets, income statements, equity changes, and cash flow statements. It also contains an accountant's review report, which is a form of limited assurance on interim financial statements. The presence of quarterly financial data and the accountant's review indicates this is an interim or quarterly financial report rather than a full annual report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2016
2016-11-11 Chinese
105年第3季財務報告書 — 201602_3164_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a combined financial report and accountant's review report for the second quarter of years 105 and 104 (Taiwanese calendar years, corresponding to 2016 and 2015). It includes consolidated financial statements such as balance sheets, income statements, statements of changes in equity, and cash flow statements. The presence of an accountant's review report (核閱報告) indicates it is a reviewed interim financial report rather than a full annual report. The document contains detailed financial data and notes, consistent with an Interim / Quarterly Report. It is not a mere announcement or certification but contains substantive financial information for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q2 2016
2016-11-11 Chinese
105年第3季財務報告書 — 201601_3164_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Accountant's Review Report" for the first quarter of 民國105年 (2016) and 民國104年 (2015). It includes detailed financial statements such as consolidated balance sheets, income statements, statements of changes in equity, and cash flow statements, along with notes to the financial statements. The presence of an accountant's review report (核閱報告) indicates it is a reviewed interim financial report rather than a full annual report. The period covered is the first quarter, which is a shorter period than a full fiscal year. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-11-11 Chinese
105年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the 105th year of the Republic of China calendar (which corresponds to 2016). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2033 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2016
2016-11-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.